A critical assessment of corticosteroid trials for hospitalised patients with SARS-CoV-2 disease.
Saved in:
| Title: | A critical assessment of corticosteroid trials for hospitalised patients with SARS-CoV-2 disease. |
|---|---|
| Authors: | Carlet J; Past president of the European Society of Intensive Care Medicine (ESICM), Past President of the World Alliance Against Antibiotic Resistance (WAAAR), past member of the International Sepsis Forum (ISF), Creteil, France. jeancarlet@gmail.com., Payen D; Paris Cité Sorbonne University; Department of Infectious Disease, Nice Alpes Cote d'Azur University, Nice, France., Singer M; University College London, London, UK. |
| Corporate Authors: | Steroids for Covid Study Group |
| Source: | Intensive care medicine [Intensive Care Med] 2025 May; Vol. 51 (5), pp. 972-974. Date of Electronic Publication: 2025 May 23. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Springer Verlag Country of Publication: United States NLM ID: 7704851 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1238 (Electronic) Linking ISSN: 03424642 NLM ISO Abbreviation: Intensive Care Med Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-1238 |
|---|---|
| DOI: | 10.1007/s00134-025-07878-1 |
